Ad is loading...
PDECX
Price
$15.48
Change
-$0.16 (-1.02%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

PDECX vs RNWFX

Header iconPDECX vs RNWFX Comparison
Open Charts PDECX vs RNWFXBanner chart's image
PGIM Jennison Emerging Markets Eq Opps C
Price$15.48
Change-$0.16 (-1.02%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
PDECX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PDECX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDECX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. PDECX (593M). RNWFX pays higher dividends than PDECX: RNWFX (1.51) vs PDECX (0.00). PDECX was incepted earlier than RNWFX: PDECX (10 years) vs RNWFX (23 years). PDECX is a more actively managed with annual turnover of: 103.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than PDECX: RNWFX (250) vs PDECX (1000). PDECX annual gain was more profitable for investors over the last year : 22.66 vs. RNWFX (11.54). PDECX return over 5 years is better than : 30.52 vs. RNWFX (17.17).
PDECXRNWFXPDECX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD14.9227.099210%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets593M60.9B1%
Annual Yield % from dividends0.001.51-
Returns for 1 year22.6611.54196%
Returns for 3 years-31.87-14.55219%
Returns for 5 years30.5217.17178%
Returns for 10 years54.3441.00133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics